Anderson S D, Schoeffel R E, Finney M
Thorax. 1983 Apr;38(4):284-91. doi: 10.1136/thx.38.4.284.
The airway response to the inhalation of ultrasonically nebulised distilled water was determined in 55 asthmatic patients and 16 normal subjects. We calculated the dose of water required to induce a 20% reduction (PD20) in forced expiratory volume in one second (FEV1) by measuring the output of the nebuliser and the volume ventilated by each subject. Forty-eight of the asthmatic patients had a PD20 of 9 ml or less but three patients required as much as 24 ml. A PD20 was not recorded in the normal subjects and the challenge was stopped after 33 ml. In 12 patients the challenge was repeated within six months and the airway response was shown to be reproducible at equivalent doses of water. In a separate group of 11 patients there was, however, a highly significant reduction in the percentage fall in FEV1 when equivalent doses of water were given on two occasions 40 minutes apart. When the temperature of the inhaled water was increased from 22 degrees C to 36 degrees C eight of 10 patients had a similar change in FEV1 with equivalent doses of water. The airways obstruction induced by the inhalation of water was readily reversed with salbutamol administered by aerosol. In some patients a challenge with water or 3.6% saline was repeated after pretreatment with sodium cromoglycate, atropine methonitrate, and verapamil hydrochloride, all given as aerosols. The airway response to the equivalent dose of water or saline was significantly reduced after treatment with sodium cromoglycate but not atropine or verapamil.
对55例哮喘患者和16名正常受试者测定了吸入超声雾化蒸馏水后的气道反应。通过测量雾化器的输出量和每个受试者的通气量,我们计算了使一秒用力呼气量(FEV1)降低20%所需的水量(PD20)。48例哮喘患者的PD20为9毫升或更少,但有3例患者需要多达24毫升。正常受试者未记录到PD20,吸入33毫升后停止激发试验。12例患者在6个月内重复进行激发试验,结果显示在等量的水激发下气道反应具有可重复性。然而,在另一组11例患者中,当相隔40分钟两次给予等量水时,如果在相隔40分钟的两个时间点给予等量的水,FEV1下降百分比有极显著降低。当吸入水的温度从22摄氏度升高到36摄氏度时,10例患者中有8例在等量水激发下FEV1有类似变化。吸入水诱发的气道阻塞可通过气雾剂吸入沙丁胺醇迅速逆转。在一些患者中,在分别用色甘酸钠、甲基硝酸阿托品和盐酸维拉帕米气雾剂预处理后,重复进行水或3.6%盐水激发试验。用色甘酸钠治疗后,对等量水或盐水的气道反应显著降低,但阿托品或维拉帕米治疗后无此效果。